ArticleMolecular therapy. Nucleic acids2026

Precision therapeutics for early onset epilepsy: Allele-selective antisense oligonucleotides for SCN2A-related epilepsy.

Olivia Kim-McManusPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.